CRSP vs MKTX · rev $11.6M vs P/E 13, rev $451.8M
Crispr Therapeutics AG (CRSP) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported MKTX revenue for 2026-06-30 was $451.8M. Net income was $146.0M. Revenue was up 93.6% from 2026-03-31 to 2026-06-30. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
CRSP currently screens at market cap $5.42B. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the CRSP and MKTX stock pages for the full models.
Not investment advice.